Clinical Trial

Ceribell Delirium Data Collection Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-07-13; most recent amendment 2025-07-22.
Status change: Not Yet Recruiting → Recruiting 2022-02-24
Trial Details
NCT Number NCT04962815
Lead Sponsor Ceribell Inc.
Conditions Delirium
Enrollment 200 participants
Start Date 2021-11-10
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-25